Phase I Clinical Trial Unit for Therapeutics

I 期治疗临床试验单位

• 批准号: 9356987
• 负责人: GEORGE SAVIOLAKIS
• 金额: $ 21.34万
• 依托单位: DYNPORT VACCINE COMPANY, LLC
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-12-15 至 2016-12-14
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9356987
• 关键词: Clinical; Clinical Trials Unit; Communicable Diseases; Investigation; Phase I Clinical Trials; Therapeutic; infectious disease treatment; novel therapeutics

The Phase I Clinical Trial Units provide a vehicle for the investigation of new therapeutic and immunomodulatory agents for the treatment of infectious disease.

I期临床试验单位为研究用于治疗感染性疾病的新型治疗和免疫调节剂提供了一种工具。